David J. Yang

4.7k total citations
145 papers, 3.7k citations indexed

About

David J. Yang is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David J. Yang has authored 145 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Radiology, Nuclear Medicine and Imaging, 38 papers in Molecular Biology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David J. Yang's work include Radiopharmaceutical Chemistry and Applications (44 papers), Medical Imaging Techniques and Applications (36 papers) and Cancer, Hypoxia, and Metabolism (19 papers). David J. Yang is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (44 papers), Medical Imaging Techniques and Applications (36 papers) and Cancer, Hypoxia, and Metabolism (19 papers). David J. Yang collaborates with scholars based in United States, Japan and China. David J. Yang's co-authors include Donald A. Podoloff, Gary O. Rankin, Patrick I. Brown, Dongfang Yu, Vonda J. Teets, Tomio Inoue, Shijie Liu, Hạixia Chen, Franklin C. Wong and Ali Azhdarinia and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

David J. Yang

138 papers receiving 3.6k citations

Peers

Countries citing papers authored by David J. Yang

Since Specialization

Citations

This map shows the geographic impact of David J. Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Yang more than expected).

Fields of papers citing papers by David J. Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Yang. The network helps show where David J. Yang may publish in the future.

Co-authorship network of co-authors of David J. Yang

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Yang. A scholar is included among the top collaborators of David J. Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Yang. David J. Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimization Processes of Clinical Chelation-Based Radiopharmaceuticals for Pathway-Directed Targeted Radionuclide Therapy in Oncology 2024 ·Pharmaceutics ·(unknown), (unknown), Firas Mourtada, Jennifer Sims‐Mourtada, (unknown), (unknown), David J. Yang, Tomio Inoue	1
2	Practical phase retrieval using double deep image priors 2023 ·Electronic Imaging ·(unknown), David J. Yang, Felix Hofmann, (unknown), Ju Sun	5
3	Efficient Synthesis of Glutamate Peptide-Estradiol Conjugate for Imaging Estrogen Receptor-Positive Diseases 2018 ·BioMed Research International ·(unknown), Sérgio D. Simon, Zhiming Jin, (unknown), (unknown), Zhihong Xu, Paulo Henrique Rosado-de-Castro, (unknown), L. M. B. da Fonseca, Tomio Inoue, David J. Yang	4
4	Patched Targeting Peptides for Imaging and Treatment of Hedgehog Positive Breast Tumors 2014 ·BioMed Research International ·Daniel L. Smith, Fanlin Kong, David J. Yang, Richard Larson, Jennifer Sims‐Mourtada, Wendy A. Woodward	6
5	Targeted Nuclear Imaging of Breast Cancer: Status of Radiotracer Development and Clinical Applications 2011 ·Cancer Biotherapy and Radiopharmaceuticals ·Fanlin Kong, (unknown), David J. Yang	9
6	Molecular imaging of Bcr-Abl phosphokinase in a xenograft model 2009 ·Molecular Cancer Therapeutics ·Ji Yuan Wu, David J. Yang, Laura S. Angelo, (unknown), Razelle Kurzrock	6
7	Presence of antibodies to non-structural proteins of foot-and-mouth disease virus in repeatedly vaccinated cattle 2006 ·Veterinary Microbiology ·F. Eun‐Hyung Lee, (unknown), David J. Yang	42
8	Assessment of Therapeutic Tumor Response Using 99mTc-Ethylenedicysteine-Glucosamine 2004 ·Cancer Biotherapy and Radiopharmaceuticals ·David J. Yang, Masashi Yukihiro, Dongfang Yu, Megumi Ito, Chang‐Sok Oh, (unknown), Ali Azhdarinia, (unknown), Jerry Bryant, Eun‐Mi Kim, Donald A. Podoloff	33
9	Assessment of Therapeutic Tumor Response Using <SUP>99m</SUP>Tc-Ethylenedicysteine-Glucosamine 2004 ·Cancer Biotherapy and Radiopharmaceuticals ·David J. Yang, Masashi Yukihiro, Dongfang Yu, Megumi Ito, (unknown), (unknown), Ali Azhdarinia, (unknown), Jerry Bryant, Eun‐Mi Kim, Donald A. Podoloff	7
10	Assessment of Antiangiogenic Effect Using ^99m Tc-EC-Endostatin 2002 ·Cancer Biotherapy and Radiopharmaceuticals ·David J. Yang, (unknown), Naomi R. Schechter, Dongfang Yu, Peng Wu, Ali Azhdarinia, (unknown), (unknown), (unknown), William E. Fogler, Jerry Bryant, Roy S. Herbst, (unknown), Eun‐Mi Kim, Donald A. Podoloff	37
11	In Vivo and In Vitro Measurement of Apoptosis in Breast Cancer Cells Using ^99m Tc-EC-Annexin V 2001 ·Cancer Biotherapy and Radiopharmaceuticals ·David J. Yang, Ali Azhdarinia, Peng Wu, Dongfang Yu, Wayne Tansey, (unknown), Eun‐Mi Kim, Donald A. Podoloff	72
12	Biodistribution and scintigraphy of [111In]DTPA-adriamycin in mammary tumor-bearing rats 1999 ·Anti-Cancer Drugs ·Tetsuya Higuchi, David J. Yang, (unknown), (unknown), (unknown), Tomio Inoue, Keigo Endo, (unknown), Donald A. Podoloff	2
13	^99m Tc-Ethylenedicysteine-Folate: A New Tumor Imaging Agent. Synthesis, Labeling and Evaluation in Animals 1998 ·Cancer Biotherapy and Radiopharmaceuticals ·Seyfettin Ilgan, David J. Yang, Takahiro Higuchi, (unknown), Hi̇kmet Bayhan, Dihua Yu, (unknown), Donald A. Podoloff	40
14	Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors. 1998 ·American Journal of Roentgenology ·Eleni Diamandidou, Jaffer A. Ajani, David J. Yang, V P Chuang, Cathy A. Brown, H Carrasco, (unknown), Sylvia M. Wallace	43
15	Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. 1997 ·PubMed ·(unknown), Germana Rappa, Rick A. Finch, David J. Yang, Richard A. Flavell, Alan C. Sartorelli	207
16	Preliminary study of cardiac accumulation of F-18 fluorotamoxifen in patients with breast cancer 1997 ·Clinical Imaging ·Tomio Inoue, E. Edmund Kim, (unknown), David J. Yang, Franklin C. Wong, P. Bassa, A. U. Buzdar, Donald A. Podoloff	12
17	Development of biodegradable ioxilan carbonate particles for contrast enhancement of the liver in computed tomography scanning: Toxicity assessment 1996 ·Academic Radiology ·Chun Li, Patricia A. McCuskey, David J. Yang, Zuxing Kan, Sidney Wallace	4
18	In vivo and electron microscopic studies of rat liver after intravenous injection of polyamino acid microspheres 1994 ·Journal of Biomedical Materials Research ·(unknown), Patricia A. McCuskey, Zuxing Kan, David J. Yang, Kenneth C. Wright, (unknown)	4
19	Nephrotoxicity of N-(3,5-dichlorophenyl)succinimide metabolites in vivo and in vitro 1988 ·Toxicology and Applied Pharmacology ·Gary O. Rankin, Hsiencheng Shih, David J. Yang, (unknown), Vonda J. Teets, Patrick I. Brown	53
20	In vitro effects of N-(3,5-Dichlorophenyl)succinimide on organic ion uptake by rat renal cortex 1986 ·Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) ·(unknown), David J. Yang, Vonda J. Teets, Gary O. Rankin	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact